Exploring AI-powered cell simulations and the launch of the world’s first virtual lab
Artificial intelligence and machine learning (AI/ML) are fundamentally changing the world of drug discovery, enabling researchers to identify the potential…
Artificial intelligence and machine learning (AI/ML) are fundamentally changing the world of drug discovery, enabling researchers to identify the potential…
Scaling up production is a key stage in the lifetime of a monoclonal antibody (mAb), fraught with the risk of…
“You may design for 12 hours,” says Xufeng Sun, Vice President of Manufacturing Science & Technology at Sharp Sterile, “but…
More than 30 million people across Europe live with a rare disease, yet fewer than 5% of these conditions have…
Targeted protein degradation (TPD) represents a transformative approach within the field of therapeutic intervention, specifically for diseases where traditional small-molecule…
When Donald Trump was elected the 47th president of the United States of America, the outlook for pharmaceuticals was unclear,…
Gene therapy holds transformative potential in treating a wide range of diseases—from cancer and genetic disorders to infectious diseases. While…
Europe has witnessed strong growth in orphan drug approvals over the past decade, yet for pharmaceutical innovators, securing market access…
Cell and gene therapies (CGTs) have established themselves as revolutionary treatment methods in the world of oncology, where they have…
The market for clinical trials in China is currently experiencing significant growth, driven by increasing activity from both Chinese sponsors…